Andrew Fein
Stock Analyst at HC Wainwright & Co.
(3.25)
# 1,060
Out of 4,761 analysts
568
Total ratings
42.73%
Success rate
3.58%
Average return
Main Sectors:
Stocks Rated by Andrew Fein
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PRTA Prothena Corporation | Reiterates: Buy | $48 | $15.56 | +208.48% | 15 | Feb 21, 2025 | |
| NBIX Neurocrine Biosciences | Reiterates: Buy | $185 | $120.69 | +53.29% | 18 | Feb 21, 2025 | |
| INSM Insmed | Reiterates: Buy | $90 | $81.06 | +11.03% | 12 | Feb 21, 2025 | |
| STOK Stoke Therapeutics | Maintains: Buy | $35 → $47 | $8.33 | +464.23% | 12 | Feb 18, 2025 | |
| CRBP Corbus Pharmaceuticals Holdings | Reiterates: Buy | $75 | $8.18 | +816.87% | 7 | Feb 18, 2025 | |
| BPMC Blueprint Medicines | Reiterates: Buy | $135 | $92.25 | +46.34% | 17 | Feb 14, 2025 | |
| BIIB Biogen | Maintains: Buy | $300 → $241 | $140.64 | +71.36% | 19 | Feb 13, 2025 | |
| VRTX Vertex Pharmaceuticals | Reiterates: Buy | $550 | $484.24 | +13.58% | 26 | Feb 11, 2025 | |
| PVLA Palvella Therapeutics | Reiterates: Buy | $38 | $19.22 | +97.71% | 4 | Feb 11, 2025 | |
| PEPG PepGen | Maintains: Buy | $16 → $26 | $1.37 | +1,797.81% | 10 | Jan 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $10 | $2.32 | +331.03% | 16 | Jan 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $17 | $3.03 | +461.06% | 12 | Jan 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $75 | $27.85 | +169.30% | 1 | Jan 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $55 | $14.01 | +292.58% | 9 | Jan 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 → $35 | $21.62 | +61.89% | 13 | Jan 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $11 | $7.46 | +47.45% | 9 | Jan 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $72 | $31.12 | +131.36% | 2 | Jan 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $90 → $87 | $20.73 | +319.68% | 20 | Jan 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $80 | $23.77 | +236.63% | 3 | Dec 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $20 → $13 | $5.23 | +148.57% | 13 | Dec 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $30 | $2.81 | +967.62% | 14 | Dec 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $100 → $47 | $11.02 | +326.50% | 12 | Dec 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $2.56 | +290.63% | 11 | Dec 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $2.17 | +591.24% | 12 | Dec 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $87 | $17.77 | +389.59% | 15 | Dec 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $23 | $3.72 | +518.28% | 13 | Dec 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $20 | $10.03 | +99.40% | 13 | Dec 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $12 | $3.30 | +263.64% | 18 | Dec 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $85 | $47.37 | +79.44% | 15 | Dec 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $12 | $1.77 | +577.97% | 15 | Nov 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $16 | $2.65 | +503.77% | 13 | Nov 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $8 | $0.97 | +724.74% | 12 | Nov 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $29 | $16.12 | +79.96% | 11 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $4 | $3.85 | +3.90% | 16 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $6 | $2.69 | +123.05% | 11 | Nov 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $22 | $11.13 | +97.66% | 10 | Nov 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $1.39 | +979.14% | 10 | Nov 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $6 → $1 | $0.17 | +473.72% | 16 | Nov 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $35 | $1.87 | +1,771.66% | 8 | Nov 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $27 | $19.95 | +35.34% | 17 | Nov 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $400 → $425 | $361.10 | +17.70% | 13 | Oct 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $25 → $35 | $4.40 | +696.36% | 11 | Oct 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $8 | $1.94 | +312.37% | 7 | Aug 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $30 | $9.21 | +225.73% | 8 | Aug 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $46 | $36.81 | +24.97% | 6 | Jun 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $17 → $7 | $3.01 | +132.56% | 6 | Nov 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $8.92 | +12.11% | 5 | Aug 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $100 → $40 | $2.60 | +1,438.46% | 3 | Feb 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $150 | $0.64 | +23,337.50% | 1 | Jan 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $10 → $3 | $0.59 | +409.25% | 4 | May 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $15 | $6.69 | +124.22% | 1 | Apr 27, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $80 → $40 | $2.62 | +1,426.72% | 3 | Mar 16, 2022 |
Prothena Corporation
Feb 21, 2025
Reiterates: Buy
Price Target: $48
Current: $15.56
Upside: +208.48%
Neurocrine Biosciences
Feb 21, 2025
Reiterates: Buy
Price Target: $185
Current: $120.69
Upside: +53.29%
Insmed
Feb 21, 2025
Reiterates: Buy
Price Target: $90
Current: $81.06
Upside: +11.03%
Stoke Therapeutics
Feb 18, 2025
Maintains: Buy
Price Target: $35 → $47
Current: $8.33
Upside: +464.23%
Corbus Pharmaceuticals Holdings
Feb 18, 2025
Reiterates: Buy
Price Target: $75
Current: $8.18
Upside: +816.87%
Blueprint Medicines
Feb 14, 2025
Reiterates: Buy
Price Target: $135
Current: $92.25
Upside: +46.34%
Biogen
Feb 13, 2025
Maintains: Buy
Price Target: $300 → $241
Current: $140.64
Upside: +71.36%
Vertex Pharmaceuticals
Feb 11, 2025
Reiterates: Buy
Price Target: $550
Current: $484.24
Upside: +13.58%
Palvella Therapeutics
Feb 11, 2025
Reiterates: Buy
Price Target: $38
Current: $19.22
Upside: +97.71%
PepGen
Jan 30, 2025
Maintains: Buy
Price Target: $16 → $26
Current: $1.37
Upside: +1,797.81%
Jan 29, 2025
Maintains: Buy
Price Target: $20 → $10
Current: $2.32
Upside: +331.03%
Jan 23, 2025
Reiterates: Buy
Price Target: $17
Current: $3.03
Upside: +461.06%
Jan 13, 2025
Reiterates: Buy
Price Target: $75
Current: $27.85
Upside: +169.30%
Jan 13, 2025
Reiterates: Buy
Price Target: $55
Current: $14.01
Upside: +292.58%
Jan 10, 2025
Maintains: Buy
Price Target: $30 → $35
Current: $21.62
Upside: +61.89%
Jan 10, 2025
Reiterates: Buy
Price Target: $11
Current: $7.46
Upside: +47.45%
Jan 10, 2025
Reiterates: Buy
Price Target: $72
Current: $31.12
Upside: +131.36%
Jan 7, 2025
Maintains: Buy
Price Target: $90 → $87
Current: $20.73
Upside: +319.68%
Dec 20, 2024
Reiterates: Buy
Price Target: $80
Current: $23.77
Upside: +236.63%
Dec 17, 2024
Reiterates: Buy
Price Target: $20 → $13
Current: $5.23
Upside: +148.57%
Dec 17, 2024
Reiterates: Buy
Price Target: $30
Current: $2.81
Upside: +967.62%
Dec 13, 2024
Reiterates: Buy
Price Target: $100 → $47
Current: $11.02
Upside: +326.50%
Dec 12, 2024
Reiterates: Buy
Price Target: $10
Current: $2.56
Upside: +290.63%
Dec 11, 2024
Reiterates: Buy
Price Target: $15
Current: $2.17
Upside: +591.24%
Dec 11, 2024
Reiterates: Buy
Price Target: $87
Current: $17.77
Upside: +389.59%
Dec 6, 2024
Reiterates: Buy
Price Target: $23
Current: $3.72
Upside: +518.28%
Dec 6, 2024
Reiterates: Buy
Price Target: $20
Current: $10.03
Upside: +99.40%
Dec 5, 2024
Reiterates: Buy
Price Target: $12
Current: $3.30
Upside: +263.64%
Dec 5, 2024
Reiterates: Buy
Price Target: $85
Current: $47.37
Upside: +79.44%
Nov 18, 2024
Reiterates: Buy
Price Target: $12
Current: $1.77
Upside: +577.97%
Nov 15, 2024
Reiterates: Buy
Price Target: $16
Current: $2.65
Upside: +503.77%
Nov 15, 2024
Reiterates: Buy
Price Target: $8
Current: $0.97
Upside: +724.74%
Nov 14, 2024
Reiterates: Buy
Price Target: $29
Current: $16.12
Upside: +79.96%
Nov 14, 2024
Reiterates: Neutral
Price Target: $4
Current: $3.85
Upside: +3.90%
Nov 13, 2024
Maintains: Buy
Price Target: $10 → $6
Current: $2.69
Upside: +123.05%
Nov 13, 2024
Reiterates: Buy
Price Target: $22
Current: $11.13
Upside: +97.66%
Nov 13, 2024
Reiterates: Buy
Price Target: $15
Current: $1.39
Upside: +979.14%
Nov 13, 2024
Downgrades: Neutral
Price Target: $6 → $1
Current: $0.17
Upside: +473.72%
Nov 7, 2024
Reiterates: Buy
Price Target: $35
Current: $1.87
Upside: +1,771.66%
Nov 7, 2024
Reiterates: Buy
Price Target: $27
Current: $19.95
Upside: +35.34%
Oct 31, 2024
Maintains: Buy
Price Target: $400 → $425
Current: $361.10
Upside: +17.70%
Oct 24, 2024
Maintains: Buy
Price Target: $25 → $35
Current: $4.40
Upside: +696.36%
Aug 8, 2024
Reiterates: Buy
Price Target: $8
Current: $1.94
Upside: +312.37%
Aug 6, 2024
Reiterates: Buy
Price Target: $30
Current: $9.21
Upside: +225.73%
Jun 17, 2024
Reiterates: Buy
Price Target: $46
Current: $36.81
Upside: +24.97%
Nov 2, 2023
Maintains: Buy
Price Target: $17 → $7
Current: $3.01
Upside: +132.56%
Aug 15, 2023
Reiterates: Buy
Price Target: $10
Current: $8.92
Upside: +12.11%
Feb 13, 2023
Maintains: Buy
Price Target: $100 → $40
Current: $2.60
Upside: +1,438.46%
Jan 31, 2023
Reiterates: Buy
Price Target: $150
Current: $0.64
Upside: +23,337.50%
May 5, 2022
Downgrades: Neutral
Price Target: $10 → $3
Current: $0.59
Upside: +409.25%
Apr 27, 2022
Assumes: Buy
Price Target: $15
Current: $6.69
Upside: +124.22%
Mar 16, 2022
Maintains: Neutral
Price Target: $80 → $40
Current: $2.62
Upside: +1,426.72%